替莫唑胺联合鞘内注射治疗术后复发的颅内恶性肿瘤临床观察
被引量:2
摘要
颅内肿瘤由于其特有的血脑屏障和特殊的端粒酶活性,以及大脑丰富的血管和供血导致颅内肿瘤血管内皮细胞生长因子受体(EGFR)高表达,普通的化疗药物无法透过血脑屏障,小分子的替莫唑胺进入颅内的血药浓度也仅能达到30%~40%,鞘内注射药物浓度过高也同样会导致中枢神经系统不可逆损伤,我们采用替莫唑胺联合鞘内注射治疗颅内肿瘤达到了比较理想的效果。
出处
《中国基层医药》
CAS
2013年第20期3177-3178,共2页
Chinese Journal of Primary Medicine and Pharmacy
参考文献10
-
1Roberto Papait, Lorenzo Magrassi, Dorotea Rigamonti, et al. Temo- zolomide and carmustine cause large-scale heterochromatin reor- ganization in glioma ceils. Biochem Biophys Res Communi ,2009, 379(2) :434-439.
-
2Payne M J, Pratap SE, Middleton MR. Temozolomide in the treat- ment of solid tumours: current results and rationale for dosing/ scheduling. Crit Rev Oncol Hemato1,2005,53 (3) :241-252.
-
3Woll PJ, Judson I, Lee SM, et al. Temozolomide in adult patients with advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer, 1999,35 ( 3 ) : 410-412.
-
4毛明辉,闫洪法,刘德全,龚惠芸,张元利,张炜.鞘内注射甲氨蝶呤和地塞米松治疗小细胞肺癌脑转移[J].肿瘤防治杂志,2004,11(2):160-161. 被引量:1
-
5Trog D, Yeghiazaryan K, Fountoulakis M, et al. Pro-invasive gene regulating effect of irradiation and combined temozolomide-radia- tion treatment on surviving human malignant glioma cells. Eur J Pharmacol,2006,542( 1/3 ) :8-15.
-
6毛明辉,闫洪法,龚惠芸,张元利,何儒鸿,张炜.甲氨喋呤鞘内注射治疗脑胶质瘤的疗效观察[J].临床神经病学杂志,2003,16(1):50-51. 被引量:1
-
7潘峰,周东风,张慈伟,等.阿糖胞苷与地塞米松联合诱导Jur-kat细胞凋亡的协周效应.实用儿科杂志,201l,26(3):166-168.
-
8Zhang YH, Yue ZJ, Zhang H, et al. Temozolomide/PLGA mierop- articles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model. Eur J Pharm Biopharm, 2010, 76 (3) :371-375.
-
9Verger E, Gil M, YaYa R, et al. Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: A phase II randdomized trial. Int J Radiat Oncol Biol Phys,2005,61 (1) :185-191.
-
10Yaman E, Buyukberber S, Benekli M, et al. Radiation induced early necrosis in patients with malignant gliomas receiving Temo- zolomide. Clin Neurol Neurosurg,2010,112 ( 8 ) :662-667.
二级参考文献8
-
1UICC 孙燕(译).成人及儿童肿瘤内科手册[M].北京:人民卫生出版社,1998.29.
-
2孙燕 周际昌.临床肿瘤内科手册:第 3版[M].北京:人民卫生出版社,1996.30.
-
3孙燕 周际昌.临床肿瘤内科手册(第 3 版)[M].北京:人民卫生出版社,1996.30-32.
-
4Wolfrom C,Hartmann R,Fengler R,et al. Randomized comparison of 36-hour intermediate-dose versus 4-hour high-dose methotrexate infusion for remission induction in relapsed childhood acute lymphoblastic leukemia[J].J Clin Oncol,1993,11(5):827-833.
-
5Hum M,Holcenberg J S,Tkaczewski I,et al. High-dose trimetrexate and minimal-dose leucovorin:a case for selective protection?[J].Clin Cancer Res Dec,1998,4(12) :2981-2984.
-
6宁廷禄.替尼泊苷和洛莫司汀加用于联合化疗中预防肺癌脑转移[J].中国癌症杂志,1999,9(2):112-114. 被引量:4
-
7王建国,杨万兰,李洪.肺癌脑转移的综合治疗探讨[J].肿瘤研究与临床,2000,12(1):41-42. 被引量:5
-
8程颖,左学荣,马丽霞.肺癌多发脑转移化疗疗效分析[J].实用肿瘤学杂志,2000,14(2):125-125. 被引量:2
同被引文献35
-
1Massimino M, Giangaspero F, Gandola L, et al. Childhood medulloblastoma[J]. Cfit Rev Oncol Hematol, 2011,79 ( 10 ) : 65-83.
-
2Koschmann C, Schmidt K J, Geyer JR, et al. Survival after recurrence of medulloblastoma in the contemporary em[J]. J Clin Oncol,2011, 29(Suppl) :2068.
-
3Feinberg DA, Mark AS. Human brain motion and cerebralspinal fluid circulation demonstrated with MR velocity imaging [J]. Radiology, 1987,16 (27) :793-795.
-
4Bossi A, Caracciolo V, Russo G, et al. Medulloblastoma from molecular pathology to therapy [J]. Clin Cancer Res,2008, 14 (4) : 971-976.
-
5Gulino A, Air.ella A, Giangaspero F. Pathologiocal and molecular heterogeneity of medulloblastoma [ J ]. Cur Opin in Oncol, 2008, 20(6) :668-675.
-
6Martin B, Nele S, Katja yon H, et al. Safety and toxicity of intrathecal liposomal cytarabine ( Depocyte ) in children and adolescents with recurrent or refractory brain tumors:a multi-institutional retrospective study[J]. Anti-Cancer Drugs ,2009,11 (9) :794-799.
-
7Gilbar PJ. Intrathecal chemotherapy: potential for medication error [ J ]. Cancer Nursing,2013,15 (5) :465-476.
-
8Sharon C, Martin G, Michael V,et al. Medulloblastoma in childhood: revisiting intrathecal therapy in infants and children [J]. Cancer Chemother Pharmacol,2010,6 ( 65 ) : 1173-1189.
-
9杨文婷,徐建生,孙强,等.全反式维甲酸抑制转基因小鼠髓母细胞瘤生长机制研究[J].国际神经病学神经外科学杂志,2009,5(9):456-461.
-
10Saito F, Hatano T, Hori M, et al. lateral and dorsal column hyperintensity on magnetic resonance imaging in a patient with myclopathy associated with intrathccal chemotherapy [J]. Case Rep Neurol,2013,5(5) : 110-115.
二级引证文献3
-
1刘海龙,曲彦明,黄铂渊,宁威海,李翰林,韩松,张宏伟,李俊发,于春江.叶酸受体介导的阿糖胞苷抑制髓母细胞瘤增殖并促其凋亡的体外实验研究[J].中华神经外科杂志,2015,31(5):514-518. 被引量:1
-
2王计伟,陈步东,杨玉山,姚鑫.成人髓母细胞瘤患者脑(脊)膜播散种植的诊断与治疗[J].中国现代神经疾病杂志,2015,15(10):826-830. 被引量:1
-
3赵倩,金眉,张大伟,赵文,张雪,李刚,冀园琦,马晓莉.4例同期治疗中进展的儿童髓母细胞瘤临床分析及经验总结[J].首都医科大学学报,2017,38(6):925-929. 被引量:1
-
1王娜,王伟文,毛庆.脑梗塞伴脑胶质瘤漏诊1例[J].肿瘤预防与治疗,2013,26(5):310-312. 被引量:2
-
2黄宁芳,唐国传,余祖辉,颜钟生,唐尚伟,陈强,李汶桎,劳显丽,黄芫,方丛丽,宋志强.三七总皂苷对急性脑梗死患者血清VEGF和VEGFR含量的影响[J].神经损伤与功能重建,2014,9(5):388-390. 被引量:6
-
3隋瑛.鞘内注射药物治疗蛛网膜下腔出血后脑血管痉挛的临床分析[J].中国处方药,2015,13(5):129-130. 被引量:2
-
4潘玉萍,庄奇新,李文彬,李明华.颅内胶质瘤伴发出血的CT和MRI诊断[J].中国临床医学影像杂志,2009,20(5):359-361. 被引量:3
-
5祝晓,祝顺达.鞘内注射药物治疗蛛网膜下腔出血后脑血管痉挛的疗效观察[J].医学理论与实践,2016,29(20):3478-3479. 被引量:1
-
6张伟丽,孙凯,祝立新,陈宇,廖玉华,万鲁红,秦勤,汪道文,马爱群,祝之明,惠汝太.血管内皮细胞生长因子受体基因编码区变异与脑卒中复发及心血管病死率的研究[J].临床心血管病杂志,2009,25(6):421-425. 被引量:13
-
7郭予大,游潮.基质金属蛋白酶与颅内病变研究进展[J].中国实用医药,2007,2(3):107-108.
-
8黄秀武,王阳华.甲氨蝶呤联合替莫唑胺对原发性中枢神经系统淋巴瘤患者的疗效分析[J].神经损伤与功能重建,2017,12(2):132-134. 被引量:4
-
9梁永平,马晓东,王宇博.高级别脑胶质瘤手术后联合放化疗疗效观察[J].军医进修学院学报,2011,32(6):557-559. 被引量:9
-
10曹新桥,王兵,石庆芳.替莫唑胺联合陀螺刀全脑放疗脑转移瘤的临床疗效[J].神经损伤与功能重建,2016,11(1):82-83.